FRE.DE - Fresenius SE & Co. KGaA

XETRA - XETRA Delayed price. Currency in EUR
67.14
+2.02 (+3.10%)
At close: 5:35PM CET
Stock chart is not supported by your current browser
Previous close65.12
Open65.32
Bid0.00 x 120700
Ask0.00 x 6100
Day's range65.22 - 67.20
52-week range60.15 - 80.07
Volume2,252,290
Avg. volume1,532,689
Market cap37.202B
BetaN/A
PE ratio (TTM)20.96
EPS (TTM)3.20
Earnings date20 Feb 2018 - 26 Feb 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Reuters14 days ago

    Fresenius CFO backs acquisition course - Boersen-Zeitung

    FRANKFURT (Reuters) - German healthcare group Fresenius (FREG.DE) will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief ...

  • Drugmaker Warned Again for Ignoring Bad Quality Tests
    Bloomberg18 days ago

    Drugmaker Warned Again for Ignoring Bad Quality Tests

    U.S. regulators warned Fresenius SE last month that workers in one of its cancer-drug plants ignored tests that found the products made there weren’t meeting sterility standards.

  • EQS Group18 days ago

    DGAP-DD: Fresenius SE & Co. KGaA english

    Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 02.01.2018 / 17:45 The issuer is solely responsible for the content of this announcement.1. Details of the person discharging managerial responsibilities / person closely associateda) NameTitle:First name:RachelLast name(s):Empey2. Reason for the notificationa) Position / statusPosition:Member of the managing bodyb) Initial notification3. ...

  • EQS Group21 days ago

    Fresenius SE & Co. KGaA: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

    Fresenius SE & Co. KGaA / Total Voting Rights Announcement31.12.2017 / 08:00 Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Publication of total number of voting rights1. Details of issuerFresenius SE & Co. KGaAElse-Kröner-Straße 161352 Bad Homburg v.d.H.Germany2. Type of capital measure Type of capital measureDate of status / date of effectXConditional capital increase (Sec. 26a para. 2 WpHG)31.12.2017 Other capital measure (Sec. 26a para. 1 WpHG)3. ...

  • Drugmaker Ignored More Than 200 Bad Quality Tests, FDA Says
    Bloomberg25 days ago

    Drugmaker Ignored More Than 200 Bad Quality Tests, FDA Says

    U.S. regulators warned Fresenius SE after the company’s Indian plant that makes cancer-drug ingredients for the U.S. market aborted hundreds of drug-quality tests because they seemed like they were going ...

  • EQS Group29 days ago

    Fresenius SE & Co. KGaA: Fresenius expects meaningful positive effects from US tax reform

    Fresenius SE & Co. KGaA / Key word(s): MiscellaneousFresenius SE & Co. KGaA: Fresenius expects meaningful positive effects from US tax reform22-Dec-2017 / 21:51 CET/CESTDisclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

  • Here's Why You Should Offload Fresenius Medical Stock Now
    Zacks2 months ago

    Here's Why You Should Offload Fresenius Medical Stock Now

    Fresenius (FMS) grapples with multiple issues. An unfavorable estimate revision trend adds to the woes.

  • Reuters2 months ago

    Fresenius says Akorn deal closure could take until next year

    German healthcare group Fresenius SE (FREG.DE) said the planned takeover of Akorn (AKRX.O), a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected. Akorn's business has deteriorated since Fresenius struck the acquisition agreement in April, valuing the maker of medical creams, ophthalmic drugs and oral liquids at $4.75 billion (3.6 billion pounds). Akorn's operating income has slumped on supply disruptions and competition for a range of drugs.

  • Foreign Stock Roundup: Toyota, Gol Linhas Beat, AstraZeneca, Fresenius Miss
    Zacks2 months ago

    Foreign Stock Roundup: Toyota, Gol Linhas Beat, AstraZeneca, Fresenius Miss

    Earnings numbers continued to guide Europe's markets last week.

  • Fresenius Medical (FMS) Q3 Earnings Miss, FY17 View Intact
    Zacks2 months ago

    Fresenius Medical (FMS) Q3 Earnings Miss, FY17 View Intact

    Strong growth in Health Care Products and Health Care Services segments drove Fresenius's (FMS) third-quarter revenues. Lackluster performance by the renal pharmaceutical segment is a concern.

  • Reuters - UK Focus5 months ago

    Miners, energy stocks give European shares another leg up

    Basic resources and energy stocks helped European benchmarks build on the previous week's robust gains on Monday, as commodity prices climbed. The pan-European STOXX 600 index rose 0.1 percent in early ...

  • Reuters - UK Focus7 months ago

    Loeb's Third Point targets 'staid' Nestle for change

    Activist investor Daniel Loeb's Third Point LLC on Sunday unveiled a more than 1 percent stake in Switzerland's Nestle SA and urged the world's largest packaged foods maker to improve its margins, buy back stock and shed non-core businesses. The stake, worth around 3.28 billion Swiss francs ($3.4 billion), is one of the largest taken by the hedge fund, which pressed for change in recent years at U.S. internet firm Yahoo (NasdaqGS: YHOO - news) and Japan's Sony Corp (Hanover: SON1.HA - news) . Third Point disclosed its Nestle position in a letter to investors, in which it argued the food company should sell its 23 percent stake in French cosmetics firm L'Oreal SA.

  • 10 things you need to know in markets today
    Business Insider9 months ago

    10 things you need to know in markets today

    1. European Union leaders will warn Britain it cannot assume its big financial services industry will be included in any free trade deal after Brexit, diplomats said on Monday after fixing negotiating terms in a draft document. Reuters reports that Britain's Prime Minister Theresa May, who will open negotiations with the EU in June assuming she wins a snap election she called last week, singled out banking and other financial services among her priorities for a future trade deal with the bloc after Brexit. 3. US paint maker PPG Industries raised its proposed offer for Akzo Nobel by about 8% to €26.9 billion (£23 billion) on Monday, increasing the pressure on its Dutch rival to enter into talks. PPG said its proposal was a "final" invitation to Akzo to enter negotiations and included a break fee in case the deal was rejected by regulators - attempting to address a concern that Akzo raised when it rejected two previous proposals from PPG.

  • Reuters - UK Focus9 months ago

    Pharma deals and BHP lead gains in flat European markets

    Gains in mining giant BHP Billiton and fresh merger and acquisition activity in the pharmaceutical sector led otherwise flat markets in Europe on Monday. The pan-European STOXX 600 index and Britain's FTSE 100 were little changed, while Germany's DAX inched 0.05 percent lower. "Markets continue to struggle to break out from of their main ranges," said Alessandro Balsotti, fund manager at JCI Capital (Other OTC: CGHC - news) in Milan.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes